GRAIL announces positive top-line results from Galleri PATHFINDER 2 study

Join Pharma | Login

	Editorial


	THE AYUSHSURAKSHA PORTAL
	Wednesday, June 18, 2025
	Misleading advertisements and health claims by the Ayurveda, Siddha and Unani drug companies have been a major issue the country has been facing for a long time now.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	GRAIL announces positive top-line results from Galleri PATHFINDER 2 study
17:00 [IST]	KARL STORZ US gets expanded indication for Solo+ Tympanostomy tube device to use in pediatric patients aged 6 to 24 months old
16:00 [IST]	Lucid Diagnostics partners with Hoag to eradicate esophageal cancer by expanding access to EsoGuard precancer testing across its extensive healthcare delivery network
15:00 [IST]	Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML
14:00 [IST]	CereVasc receives Health Canada investigational testing authorization to conduct STRIDE trial to evaluate eShunt System
13:00 [IST]	Palvella Therapeutics’ drug candidate QTORIN rapamycin receives US patent

more news >>

TOP NEWS


08:00 [IST]	PCI asks institutions to submit appeal regarding statutory documents for AY25-26
08:00 [IST]	TN PTA to organise protest meeting on June 25 against OTC policy & e-pharmacy
08:00 [IST]	India needs multi-pronged strategy to meet demand for blood & cord blood: Dr Mrinalini Chaturvedi
08:00 [IST]	DGTR to hold oral hearing on anti-dumping investigation into PTFE imports from China and Russia on July 2
08:00 [IST]	Telangana DCA seizes counterfeit versions of Rosuvas F 20 & Rosuvas F 10 from distributors in Hyderabad
08:00 [IST]	DGTR reschedules hearing in DASDA anti-dumping investigation as domestic industry shares evidence of losses

more news >>

YESTERDAY'S NEWS


18:00 [IST]	JCR Pharma introduces mucopolysaccharidosis type II disease awareness film featured in the Next Frontier series
17:00 [IST]	Kindeva joins forces with Rocket Science Health to pioneer new intranasal delivery platform
16:45 [IST]	S.L. Raheja Hospital launches AI-enabled Digital PET CT, 3T-MRI, and advanced NICU-PICU units
16:00 [IST]	Saptalis Pharma launches fluoxetine oral solution, USP 20 mg/5 mL for treatment of mental health conditions
15:45 [IST]	186 drug samples tested by the Centre and states in May as NSQs
13:45 [IST]	Pristyn Care’s digitally integrated, positioned as patient-first hospitals set new benchmarks in secondary care across Gurgaon, Hyderabad, and Kochi

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

Diethylcarbamazine 100 Mg Tab Furosemide 50 Mg / 5 Ml Syrup, Indapamide 1.5mg Tab, Torsemide 10 Mg / Ml 2 Ml Amp S-amlodipine 5 Mg Tab, Nifedipine 5 Mg Cap Normal Saline 1000 Ml Bot Ruxolitinib 20 Mg Tablet

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers